Navigation Links
HudsonAlpha and UAB researchers work to identify optimal treatments for ER+ breast cancer
Date:8/1/2013

HUNTSVILLE, Ala. The most commonly diagnosed form of breast cancer, termed estrogen receptor positive or ER+, accounts for the largest percentage of breast cancer deaths each year. Research by scientists at the HudsonAlpha Institute for Biotechnology and the University of Alabama at Birmingham Comprehensive Cancer Center aims to provide physicians a more targeted approach to treating ER+ breast cancer.

"Can we find something in the genome that correlates with those patients who respond to treatment as opposed to those who do not?" posed Rick Myers, Ph.D., president and director of HudsonAlpha. Myers, principal investigator on the nearly $1 million grant recently awarded by Susan G. Komen for the Cure, said researchers have an unprecedented opportunity to identify molecular signatures that could mean faster, more effective treatments.

Myers, along with Katherine Varley, Ph.D., at HudsonAlpha, and Andres Forero, M.D., and Don Buchsbaum, Ph.D., of the UAB Comprehensive Cancer Center, will evaluate the genetic composition of breast cancer cells obtained from an investigator initiated trial that combined two medications; one that blocks estrogen action and the other a monoclonal antibody that blocks formation of vessels in the tumors. The patients with ER+ breast cancer participating in the trial provided biopsy specimens from primary tumors prior to treatment and at six weeks after the initiation of therapy. Physicians and scientists at UAB, including Forero and Buchsbaum, led the clinical trial.

"The trial involved a unique combination of drugs," said Myers, "and some women responded well to the treatment and others did not. With this Komen award, we will use new technologies to examine all the genes the entire genomes in the tumor tissues from the women who participated, in hopes of identifying molecular signatures specific for those who respond versus those who do not respond." Physicians could then use these signatures, or bi
'/>"/>

Contact: Holly Ralston
hralston@hudsonalpha.org
256-508-8954
HudsonAlpha Institute for Biotechnology
Source:Eurekalert

Page: 1 2

Related biology news :

1. HudsonAlpha awarded grant to improve diagnoses of childhood genetic disorders
2. UPCI researchers target cell sleep to lower chances of cancer recurrence
3. U-M researchers land $2M grant to cooperate with nature on growing algae for energy
4. UT Southwestern researchers identify novel mechanism that helps stomach bug cause illness
5. Researchers uncover cellular mechanisms for attention in the brain
6. Notre Dame researchers develop system that uses a big data approach to personalized healthcare
7. U of M researchers unveil nations first porcine virus rapid detection test
8. Researchers reveal the clearest new pictures of immune cells
9. Researchers describe potential for MERS coronavirus to spread internationally
10. U of M researchers identify new functions for autoimmune disease risk gene
11. Solving DNA puzzles is overwhelming computer systems, researchers warn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:4/2/2015)... 2015 At its 2015 ACMG Annual Clinical ... , the American College of Medical Genetics and Genomics ... its Board.  Members of the ACMG Board of Directors ... and advancing its policies and programs. ACMG is the ... "It,s an eventful time in medical genetics and genomics.  ...
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... time in 11 years, USC Associate Professor Ellis Meng ... the classroom not answering them. Meng, whose ... medication-delivery system, is enrolled in a business crash-course sponsored ... customers, develop viable business models, and get on the ...
... with endless color, but physiologically the human eye sees only ... a Tel Aviv University-developed technology is using colors invisible to ... With the ability to detect more than 1,000 colors, the ... used to "diagnose" contaminants and other environmental hazards in real ...
... Ga. Examining the chin and upper and lower abdomen ... hair growth in women, a key indicator of too much ... way to identify this problem in women that was as ... endocrinologist and President of Georgia Health Sciences University. ...
Cached Biology News:USC scientist's revolutionary drug pump draws NSF support 2Thousand-color sensor reveals contaminants in Earth and sea 2Women's chin, abdomen are good indicators of excessive hair growth 2Women's chin, abdomen are good indicators of excessive hair growth 3
(Date:5/5/2015)... , May 5, 2015  Tikcro Technologies Ltd. ... approved to continue trading on OTCQB  Marketplace, the ... OTCQB Marketplace allows for a continuous public market ... can have real-time quotes and market information on ... The OTCQB Marketplace includes U.S. and international companies ...
(Date:5/5/2015)... NEW YORK , May 5, 2015 /PRNewswire/ ... today announced that Andrew Gengos , President and ... on May 7, 2015. DATE:  Thursday, May ... LINK:  http://VirtualInvestorConferences.com > click the ... will be a live, interactive online event where ...
(Date:5/5/2015)... May 05, 2015 Research and Markets ... of the "Clinical Laboratory, Molecular Diagnostics and ... to 2019 - Global Version" report to ... in the area of molecular diagnostics and pharmacogenics ... evolving world market that is moving out of ...
(Date:5/5/2015)... 2015   Tocagen Inc. , a clinical-stage ... Parkinson , M.D., a venture partner at New ... board of directors of Tocagen. Dr. Parkinson has ... clinical development, including leading clinical activities at Amgen ... the cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and ...
Breaking Biology Technology:Tikcro Technologies Announces Approval to Continue Trading on OTCQB 2ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... Inc have successfully implemented Amphora,s PatentSafe solution to ... PatentSafe as a fully electronic lab notebook, with ... efficiently into today,s laboratories but it also allows ... and effectively, saving significant time previously spent on ...
... Sky One,Medical, Inc. ("China Sky One Medical" or "the ... pharmaceutical company producing over-the-counter,drugs in the People,s Republic of ... quarter and fiscal year ended December 31,2008. , , ... -- Total revenues increased 104.0% year-over-year to $26.0 ...
... Hovione is pleased to announce,that its licensee Daiichi ... use Hovione,s TwinCaps(R) dry powder inhaler device in ... neuraminidase inhibitor active,against the influenza virus. Daiichi Sankyo ... in Japan and other Asian countries and results,are ...
Cached Biology Technology:Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 2Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 2China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 4China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 5China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 6China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 7China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 8China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 9China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 10Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza 2Hovione's TwinCaps(R) Inhaler in Phase III Clinical Trials for Influenza 3
... anti-phospho-IRS1 (Tyr896) ... to amino acid region encompassing ... phospho-IRS1 (Tyr896). ... Quality Assurance: ...
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236...
...
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
Biology Products: